Kunanusornchai W, Witoonpanich B, Tawonsawatruk T, Pichyangkura R, Chatsudthipong V, Muanprasat C
I logged my personal experience: the good, bad, and ugly
(History + Background) IGF-1 DES , or Insulin-like Growth Factor 1 DES(1-3) , is a modified version of IGF-1 a powerful anabolic growth factor that plays a critical role in: Muscle growth Tissue repair Recovery Cellular regeneration It is essentially a truncated form of native IGF-1: 13 amino acids shorter than full-length IGF-1 Lacks the first three N-terminal amino acids (hence the name DES(1-3) ) This structural modification gives IGF-1 DES two unique properties: Greatly increased receptor binding affinity 10x more potent locally vs
There are ongoing studies to understand the risks associated with taking the drug, particularly related to thyroid cancer and mental health side effects
it does not establish that reducing to 0.5 or 1.0 mg will hold the same plateau. One milligram has direct weight-loss evidence as an assigned treatment arm in type 2 diabetes, while small uncontrolled series suggest that dose reduction or reduced-frequency dosing can sometimes hold a plateau. No trial has established a Semaglutide step-down schedule
Next-Generation Beneficial Microbes: The Case of Akkermansia Muciniphila